Personalizing Cancer Therapy via mitochondrial functional assays with BH3 profiling

Prof. Anthony G. Letai, MD, PhD
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Thursday, September 12, 2019 - 4:00pm
PMH, 610 University Avenue, 6th Floor Auditorium, Rm 6-604
Invited Speaker Seminar
Host: 
Dr. Steven Chan
Princess Margaret Seminar Series